Doctor Care Anywhere Group’s (DOC) Q122 results showed continuing revenue momentum from FY21, as well as a significant expansion in its gross margin as the costs of delivering consultations reverted to more normalised levels. Over the quarter, DOC significantly reduced its overheads and believes the platform’s operating leverage will allow it to scale and reach its goal of EBITDA run-rate profitability by H123.
Sustained positive momentum
In Q122, DOC achieved underlying revenue growth of 95% y-o-y (+9% q-o-q) to £8.6m. The annualised revenue run rate was £34.4m, providing visibility for management’s reaffirmed guidance of FY22 revenue of at least £35–38m (>40% year-on-year).
As a doctor founded, patient-focused company, Doctor Care Anywhere plc (ASX:DOC) believe that happy doctors mean happy patients. It’s a virtuous circle and one that we’ve built a great team to help keep going.